Identification of COL6A1 as a differentially expressed gene in human astrocytomas

Genetics and Molecular Research

Volumn 7, Issue 2, 2008, Pages 371-378

  Fujita, A ^a   Sato, J R ^a   Festa, F ^a   Gomes, L R ^a   Oba Shinjo, S M ^a   Marie, S K N ^a   Ferreira, C E ^a   Sogayar, M C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Astrocytomas; COL6A1 gene; Differential gene expression; SAGE; Tumor marker

Indexed keywords

TUMOR MARKER;

ARTICLE; ASTROCYTOMA; COL6A1 GENE; GENE EXPRESSION; GENE IDENTIFICATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MARKER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION;

EID: 47949092120     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol7-2gmr432     Document Type: Article

References (22)

1. Akbasak A and Sunar-Akbasak B (1992). Oncogenes: cause or consequence in the development of glial tumors. J. Neurol. Sci. 111: 119-133.
2. Behin A, Hoang-Xuan K, Carpentier AF and Delattre JY (2003). Primary brain tumours in adults. Lancet 361: 323-331.
3. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
4. Colin C, Baeza N, Bartoli C, Fina F, et al. (2006). Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using suppression subtractive hybridization. Oncogene 25: 2818-2826.
5. Engel J, Furthmayr H, Odermatt E, von der Mark H, et al. (1985). Structure and macromolecular organization of type VI collagen. Ann. N. Y. Acad. Sci. 460: 25-37.
6. Fisher RA (1936). The use of multiple measurements in taxonomic problems. Ann. Eugenics 7: 179-188.
7. Liang Y, Bollen AW and Gupta N (2008). CC chemokine receptor-2A is frequently overexpressed in glioblastoma. J. Neurooncol. 86: 153-163.
8. Livak KJ and Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
9. Louis DN, Pomeroy SL and Cairncross JG (2002). Focus on central nervous system neoplasia. Cancer Cell 1: 125-128.
10. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, et al. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114: 97-109.
11. Marie SK, Okamoto OK, Uno M, Hasegawa AP, et al. (2008). Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int. J. Cancer 122: 807-815.
12. Nutt CL, Mani DR, Betensky RA, Tamayo P, et al. (2003). Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 63: 1602-1607.
13. Persson O, Krogh M, Saal LH, Englund E, et al. (2007). Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets. J. Neurooncol. 85: 11-24.
14. Rickman DS, Bobek MP, Misek DE, Kuick R, et al. (2001). Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 61: 6885-6891.
15. Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, et al. (2000). Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res. 60: 6617-6622.
16. Sasaki T, Arai H, Beppu T and Ogasawara K (2003). Detection of gene amplification and deletion in high-grade gliomas using a genome DNA microarray (GenoSensor Array 300). Brain Tumor Pathol. 20: 59-63.
17. Student (1908). The probable error of a mean student. Biometrika 6: 1-25.
18. Tanwar MK, Gilbert MR and Holland EC (2002). Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res. 62: 4364-4368.
19. Tukey JW (1977). Exploratory Data Analysis. Addison-Wesley, Reading.
20. van den Boom J, Wolter M, Kuick R, Misek DE, et al. (2003). Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am. J. Pathol. 163: 1033-1043.
21. van den Boom J, Wolter M, Blaschke B, Knobbe CB, et al. (2006). Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription- polymerase chain reaction. Int. J. Cancer 119: 2330-2338.
22. Vedoy CG and Sogayar MC (2002). Isolation and characterization of genes associated with the anti-tumor activity of glucocorticoids. Brain Res. Mol. Brain Res. 106: 57-69.